A polymer composite spray was shown to not only limit SARS-CoV-2 infection, but also hinders transmission in this proof-of-concept study.
Pioneers in Science: Katalin Karikó
Demoted from her tenure track position in the mid 90s, Katalin Karikó persisted with her research into RNA therapeutics and is now senior vice president of BioNtech.
How do viruses protect their genetic information?
Researchers uncover the mystery of how viruses avoid encapsulating unwanted genetic material from the crowded cell cytoplasm.
COVID-19 clinical trials lack diversity
Trials need more people of color to generalize results to larger US population.
Reusable face masks that kill pathogens
Researchers develop a reusable filter paper made from titanium dioxide nanowires that is capable of trapping and killing pathogens like the SARS-CoV-2 virus.
The route of all COVID-19 evil: RNA
RNA-related processes that are key to the biology of the cell are at risk during coronavirus infections.
Scientists aim gene-targeting breakthrough against COVID-19
Lipitoids, which self-assemble with DNA and RNA, could serve as cellular delivery systems for antiviral therapies that prevent COVID-19 and other coronavirus infections.
Human-on-a-chip provides an accurate model for the immune system
A new in vitro model of the body’s immune system better predicts its response to new therapeutics, potentially lowering the high costs and low success rates of drug discovery.
No evidence of benefit from chloroquine and hydroxychloroquine in COVID-19 patients
A study that analyzed data from nearly 15 000 patients with COVID-19 receiving four combinations of chloroquine, hydroxychloroquine, and antibiotics indicates the drug regimen may be doing more harm than good.
Twin antibodies show neutralizing activity against SARS-CoV-2
Scientists identify a cocktail of antibodies from a recovered COVID-19 patient’s blood sample that helped neutralize the SARS-CoV-2 virus in mice.